Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer
NCT01715363 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2016-02-10
Summary
The purpose of this study is to analyze the clinical tolerance of immediate preoperative chemotherapy in terms of toxicity and perioperative morbidity and mortality
Conditions
- Patients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated
Interventions
- DRUG
- DRUG
-
Folinic Acid
- DRUG
-
Fluorouracile
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
lead OTHER
Principal Investigators
-
Diane GOERE, MD · Gustave Roussy, Cancer Campus, Grand Paris
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- France
Study Locations
More Related Trials
-
A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases
NCT01260415 ·Status: COMPLETED ·Phase: PHASE2
-
Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer
NCT01060007 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine
NCT02665312 ·Status: UNKNOWN
-
Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy
NCT01378143 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases
NCT00268398 ·Status: COMPLETED ·Phase: PHASE3
-
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
NCT00537823 ·Status: TERMINATED ·Phase: PHASE2
-
Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer
NCT01013805 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
NCT00513266 ·Status: UNKNOWN ·Phase: PHASE2
-
Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer
NCT02849106 ·Status: COMPLETED ·Phase: NA
-
The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer
NCT00833131 ·Status: UNKNOWN ·Phase: PHASE3
-
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
NCT00831181 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer
NCT00205322 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
NCT00006479 ·Status: UNKNOWN ·Phase: PHASE3
-
NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
NCT03259035 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer
NCT03487939 ·Status: UNKNOWN ·Phase: PHASE2
-
Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin
NCT02087475 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy
NCT00986440 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer
NCT03781323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer
NCT01972503 ·Status: UNKNOWN ·Phase: PHASE4
-
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
NCT01515787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer
NCT00008060 ·Status: COMPLETED ·Phase: PHASE3
-
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
NCT00138177 ·Status: COMPLETED ·Phase: PHASE1
-
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
NCT02232152 ·Status: COMPLETED ·Phase: PHASE1
-
Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer
NCT00807911 ·Status: COMPLETED ·Phase: PHASE2
-
Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy
NCT01126866 ·Status: TERMINATED ·Phase: PHASE2